Rituximab


Content provided by Healthwise
small text medium text large text

Examples


Brand Name Chemical Name
Rituxanrituximab

Rituximab is available for intravenous (IV) use.


How It Works


Rituximab belongs to a group of medications known as monoclonal antibodies. It is designed to recognize specific proteins that are found on the surface of some lymphoma cells. The monoclonal antibody recognizes the protein and locks onto it (like a key in a lock). This may then trigger the body's immune system to attack and destroy the cancer cells.


Why It Is Used


Rituximab is used in combination with other chemotherapy medications to treat non-Hodgkin's lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Rituximab is used with ibritumomab as part of targeted radiation therapy.


How Well It Works


Rituximab is an effective treatment for NHL and CLL. It is used in combination with other chemotherapy medications.1


Side Effects


Side effects of rituximab are common and may include:

  • Fever and chills. This is more common within the first 1 to 2 hours of the first infusion.
  • Swelling of the face, lips, and eyelids (angioedema).
  • Flushing.
  • Nausea or vomiting.
  • Skin rash.
  • Headache.
  • Sore throat.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)


What To Think About


Rituximab should be administered only under the supervision of a medical oncologist or hematologist.

In some cases, rituximab has been associated with serious side effects such as breathing difficulty, heart problems, or severe infection. For this reason, the use of rituximab is closely watched.

Rituximab may make heart damage worse in people who already have heart disease. Frequent tests are needed to monitor heart function while taking this medication.

In some people who have a history of hepatitis B virus (HBV) infection, rituximab may cause the virus to begin multiplying again, leading to severe liver problems. These people should have tests to monitor liver function during and for several months following rituximab treatment. Also, people who have a high risk of HBV infection should be screened before starting treatment with rituximab to make sure an HBV infection is not present.

Rituximab may cause birth defects. Do not use this medication if you are pregnant or wish to become pregnant or father a child while you are taking it.

Rituximab has only been approved for use by adults. There is no specific information comparing use of rituximab in children.

Complete the new medication information form (PDF) (What is a PDF document?) to help you understand this medication.


References


Citations

  1. Coiffier B, et al. (2002). CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. New England Journal of Medicine, 346(4): 235–242.


Credits


Author Robin Parks, MS
Editor Kathleen M. Ariss, MS
Associate Editor Tracy Landauer
Associate Editor Pat Truman
Associate Editor Terrina Vail
Primary Medical Reviewer Caroline S. Rhoads, MD

- Internal Medicine
Specialist Medical Reviewer Douglas A. Stewart, MD

- Medical Oncology
Last Updated June 12, 2006

|Print Print This

Healthwise Logo
Last updated: June 12, 2006
Author: Robin Parks, MS
Reviewed By: Caroline S. Rhoads, MD - Internal Medicine, Douglas A. Stewart, MD - Medical Oncology
Editors: Kathleen M. Ariss, MS, Terrina Vail

This information is not intended to replace the advice of a doctor. By using AOL Body, you indicate that you have read, understood, and agreed to our Terms of Service, and AOL Body Advertising Policy. Read more about our content partners.

Search


Where Does it Hurt?

body symptoms

If you're experiencing aches and pains we can help you find answers. Find out what your symptoms mean for your health.